PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 12, 2025Journal of Nanobiotechnology2 citationsOpen Access

Au-g-C3N4@MIL-100/Pt@CuS-induced self-accelerated dual-quenching ECL-RET strategy for sensitive sST2 detection

View Full Paper
XHXing HeZAZhijun AiDYDiao Yu

Key Points

  • This work aims to develop a dual-quenching ECL-RET strategy for sensitive detection of sST2 in heart failure.
  • Developed an ECL immunosensor for sST2 detection using Au-g-C3N4@MIL-100/Pt@CuS materials.
  • Utilized reversible Fe2+/Fe3+ cycling in MIL-100 to enhance ECL emission.
  • Incorporated Au nanoparticles to facilitate electron transfer and biomolecular immobilization.
  • Achieved a linear detection range of 0.001-100 ng mL-1 for sST2.
  • Demonstrated an ultralow detection limit of 0.547 pg mL-1 for sST2 detection.
  • Established a reliable platform for sST2 quantification, advancing heart failure research.

Abstract

A novel dual-quenching electrochemiluminescence (ECL) immunosensor based on ECL resonance energy transfer (ECL-RET) strategy was developed for sensitive detection of soluble suppression of tumorigenicity 2 (sST2) protein. The sensor developed a self-accelerated ECL emitter composed of Au-decorated graphitic carbon nitride (g-C3N4) nanosheets and Materials of Institute Lavoisier-100(Fe) (MIL-100(Fe)). In this system, the reversible Fe2+/Fe3+ redox cycling in MIL-100(Fe) markedly enhanced the ECL emission from the g-C3N4/S2O82- pair by promoting the generation of sulfate radical. Simultaneously, the incorporated Au nanoparticles facilitated electron transfer and provided abundant sites for biomolecular immobilization, collectively establishing a robust "signal-on" state. Signal quenching was achieved using Pt@CuS nanoflowers as synergistic ECL quenchers. Their high antibody-loading capacity and efficient ECL-RET capability acted in concert to drastically reduce the signal, thereby inducing a pronounced "signal-off" state. The optimized "on-off" ECL immunosensor demonstrated a satisfactory linear range (0.001-100 ng mL-1) and an ultralow detection limit of 0.547 pg mL-1 for sST2. This work established a reliable platform for sST2 quantification, holding substantial potential for advancing heart failure research and clinical early diagnosis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

He et al. (2025) studied this question.

synapsesocial.com/papers/6941aae10f5af7fd17df5958https://doi.org/10.1186/s12951-025-03866-1
Ask AI
Helpful
Bookmark
Share
View Full Paper